Editorial draft · writing/policy-storming-heaven-research-funding

Public vs. Private: Who Funds the Psychedelic Research Program

Education, not medical advice. Drafts and study material from an independent research library. Citations on this page were checked on Oct 13, 2026; claims in the body text and organizational sources are still under review. What was checked.

Policy PieceStorming Heaven222 words4 source entriesstatus: editorial complete

Public vs. Private: Who Funds the Psychedelic Research Program

“In the 1950s, the CIA and NIH both funded psychedelic research simultaneous…”policyhistory

“In the 1950s, the CIA and NIH both funded psychedelic research simultaneously. In 2026, NIH contribution remains minimal. Private capital has filled the gap, and private capital has its own incentive structure.”

Stevens documented in Storming Heaven that the 1950s-1960s psychedelic research program had two simultaneous government funders: the CIA (through MK-Ultra, interested in weaponization) and the NIH (through legitimate research grants). Both ended with the 1968-1970 prohibition.

The current renaissance has been funded primarily by private capital rather than federal sources. A psilocybin developer has raised over $300 million from venture capital and public markets. MAPS has raised over $100 million from philanthropic sources. The commercial pipeline of psychedelic biotech companies has attracted over $1 billion in investment since 2018.

NIH funding for psychedelic research has increased but remains a small fraction: approximately $20-30 million annually as of 2024-2025, compared to hundreds of millions from private sources. The research program is primarily driven by investors who need regulatory approval to generate returns.

This creates structural conditions Stevens identified as a risk: when financial interests drive the research agenda, questions being answered are those relevant to commercialization rather than the full range of therapeutic, cultural, and scientific applications. Cluster headaches, no large commercially attractive population, are not being funded. Indigenous ceremonial uses, no proprietary IP, are not being funded.

Osmond and Hoffer's Saskatchewan research was publicly funded provincial health research. The questions were driven by clinical need and scientific curiosity. The current program's questions are shaped by venture capital. The difference is not irrelevant.